L.O.M. Medical International Inc.
Newsletter & Update
Volume 3, Issue 4
Page 2
October/November 1999
Secretary
of Labor in
the U.S.A.
Plans to
Combat
Needlestick
Injuries
The Occupational Safety and Health
Administration is seeking to reduce the number of
needlestick injuries to healthcare workers. Such
injuries may spread illnesses and disease such as
hepatitis and AIDS or HIV. They have estimated
that 590,000 injuries occur from needlesticks
each year.
The Secretary of Labor, Alexis M. Herman,
announced his opinions regarding this issue in a
National News release on May 20, 1999. He
said, "Safer needle devices mean fewer
needlesticks for healthcare workers. It is time
to make sure that healthcare workers have
up-to-date medical devices that limit the risk
of needlesticks and the potential for
developing deadly diseases such as AIDS and
hepatitis."
OSHA is taking many steps to reduce the risks of
healthcare workers contracting such diseases
from needlestick injuries. The report has indicated
that proper training, education, and the use of
safer medical devices have proven to play an
important role in reducing such risks.
OSHA Administrator, Charles N. Jeffress stated
"Health care workers strive to keep us
healthy. We now have an opportunity to
provide them with protection from the hazards
of sharps and needlestick injuries that can
threaten their heatlh and well-being. It's time
to move forward."
OSHA National News Release, U.S. Department of
Labor, Office of Public Affairs, USDL: 99-145,
Thursday May 20, 1999
HIV via Needlesticks: How can
it be prevented? In many cases, the
spread of HIV can be prevented. Prevention
of HIV transmission to health care workers
and care givers include the use of a safety
syringe, safe work practices that do not
allow the recapping of needles, (i.e. the
L.O.M. Retractable Syringe) and the use of
personal protective equipment like masks,
protective eyewear, and vinyl gloves (a lot of
allergies occur from latex). Also, in drug
users, a safer retractable syringe like the
L.O.M. Retractable, would not allow the
sharing of needles as the syringe
automatically retracts the needle and locks it
into it's own sealed chamber. This would
prevent a lot of drug users who are infected
with HIV or Hepatitis from spreading this
disease via their needlesticks.
L.O.M. Directors' Meeting: On
September 25th, 1999, the Directors of
L.O.M. Medical International Inc., met in
the Vancouver office boardroom for a
scheduled board meeting. The topics
discussed included: the annual audit and
interm financial statements; reports to SEC.
and NASDQ; reports on J. Alexander and
Thomas Stepp pertaining to commencement
of trading; quarterly and anually financial
projections; report on negotiations with
banks & brokerages; commencement of
publically trading; share sales; production &
marketing; new products; newsletters and
correspondence.
Odds n' Ends: The
company is presently
promoting its Eye Care
Products in the United
States.
L.O.M. is in the final
stages of taking on
another product line for
North America that has FDA approvals and
DIN Numbers for the U.S. and Canada.
This Product is presently being marketed in
Europe as a medical, pharmaceutical, and
"hospital use" product. The product line
deals with skin disorder treatments, and has
proven to be very effective in the treatment
of Psoriasis, Eczema, and Acne. It has also
proven to be very effective for use on burn
unit patients.
L.O.M. Medical International
Inc.
Headquarters
Suite #3-1482 Springfield Road
Kelowna, B.C., Canada V1Y 5V3
Tel.: (250) 762-7552
Fax: (250)762-6988
KELOWNA E-MAIL
Vancouver Office
Suite 580 - 885 Dunsmuir
Street
Vancouver, B.C., Canada
V6C 3L6
Tel.: (604) 602-9400
Fax: (604) 602-9409
VANCOUVER E-MAIL
bcjt |
